Zobrazeno 1 - 10
of 1 398
pro vyhledávání: '"Booster vaccination"'
Autor:
McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall H, Marsh J, Estcourt MJ, Ramsay J, Wadia U, Williams PCM, Tjiam MC, Blyth C, Subbarao K, Nicholson S, Faust S.N., Thornton RB, Mckenzie A, Snelling T, Richmond P
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Coronavirus-2019 (COVID-19) vaccination in Australia commenced in February 2021. The first vaccines recommended for use were AZD1222 and BNT162b2, both delivered as a two-dose primary schedule. In the absence of sustained immunity
Externí odkaz:
https://doaj.org/article/bf1529a9360c49c191e21caa73f4ccfa
Publikováno v:
Journal of Nursing Practice, Vol 8, Iss 1, Pp 70-83 (2024)
Background: Positive mental health (PMH) response for families who have schizophrenic patients in the implementation of vaccination is a double burden that occurs in efforts to prevent the Covid-19 Virus in schizophrenic patients. Purpose: The stud
Externí odkaz:
https://doaj.org/article/844e31f49f354df1bbdaab0f2948a9cd
Autor:
Theresia Santi, Ari Prayitno, Zakiudin Munasir, Sri Rezeki S. Hadinegoro, Alida Roswita Harahap, Retno Asti Werdhani, Ivo Novita Sah Bandar, Juandy Jo, Badriul Hegar
Publikováno v:
Paediatrica Indonesiana, Vol 64, Iss 5, Pp 447-53 (2024)
Background Diphtheria can be effectively prevented by adequate immunization. A combined vaccine against diphtheria toxoid, pertussis, and tetanus toxoid (DPT) is currently used in routine pediatric immunizations. Outbreaks of diphtheria could emerge
Externí odkaz:
https://doaj.org/article/c54eeb09bc6b4b128bdaca9e8794a896
Autor:
Masae Itamochi, Shunsuke Yazawa, Yumiko Saga, Takahisa Shimada, Kosuke Tamura, Emi Maenishi, Junko Isobe, Hitoshi Sasajima, Chikako Kawashiri, Hideki Tani, Kazunori Oishi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Residents in nursing homes face heightened COVID-19 risks. We aimed to assess the adverse events (AEs) rates and antibody responses after the first to the fifth dose of COVID-19 mRNA vaccination in a nursing home cohort. Ninety-five SARS-CoV
Externí odkaz:
https://doaj.org/article/85ab8979fe53416193d0cfd710d125b1
Autor:
Brittany A. Zulkiewicz, Allison Li, Gretel Tassah, Minnie Kim, Karen Glanz, Antonia Villarruel, Jose A. Bauermeister, Terri Lipman, Stephen Bonett, Ufuoma Oyiborhoro, Andy S. L. Tan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Formative research is an important component of health communication campaign development. Rapid message testing approaches are useful for testing new messaging quickly and efficiently during public health emergencies, such as COVID-19, when
Externí odkaz:
https://doaj.org/article/07e4f7a49f4a4f959d653fe8e92ee3d7
Autor:
Wang-Da Liu, Meng-Shuan Lin, Hsin-Yun Sun, Ming-Chieh Shih, Yu-Chung Chuang, Yu-Shan Huang, Kuan-Yin Lin, Guei-Chi Li, Pei-Ying Wu, Ling-Ya Chen, Wen-Chun Liu, Yi-Ching Su, Pu-Chi He, Yi-Ting Chen, Chia-Yi Lin, Yu-Chen Cheng, Yi Yao, Yi-Chen Yeh, Chia-Chi Liu, Mei-Yan Pan, Yu-Zhen Luo, Hsi-Yen Chang, Jann-Tay Wang, Wang-Huei Sheng, Szu-Min Hsieh, Sui-Yuan Chang, Chien-Ching Hung
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 4, Pp 554-563 (2024)
Background: Real-world vaccine effectiveness following the third dose of vaccination against SARS-CoV-2 remains less investigated among people with HIV (PWH). Methods: PWH receiving the third dose of BNT162b2 and mRNA-1273 (either 50- or 100-μg) wer
Externí odkaz:
https://doaj.org/article/590aff5ae8c443e9a1c648ed491e8f65
Autor:
Milja Belik, Arttu Reinholm, Pekka Kolehmainen, Jemna Heroum, Sari Maljanen, Eda Altan, Pamela Österlund, Larissa Laine, Olli Ritvos, Arja Pasternack, Rauno A. Naves, Alina Iakubovskaia, Alex-Mikael Barkoff, Qiushui He, Johanna Lempainen, Paula A. Tähtinen, Lauri Ivaska, Pinja Jalkanen, Ilkka Julkunen, Laura Kakkola
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMutations occurring in the spike (S) protein of SARS-CoV-2 enables the virus to evade COVID-19 vaccine- and infection-induced immunity.MethodsHere we provide a comprehensive analysis of humoral and cell-mediated immunity in 111 healthcare
Externí odkaz:
https://doaj.org/article/523052bbfb674ef28047590dedb58f43
Autor:
Laura Donadeu, Susana Gomez-Olles, Franc Casanova, Alba Torija, Manuel Lopez-Meseguer, Meritxell Boada-Pérez, Delphine Kervella, Elena Crespo, Claudia Carrera-Muñoz, Isabel Campos-Varela, Lluís Castells, Maria F. Cortese, Juliana Esperalba, Candela Fernández-Naval, Jesús Quintero, Marina Muñoz, Fernando Agüero, José Gonzalez-Costello, Laura Lladó, Alexandre Favà, Laura Cañas, María del Mar de la Hoz-Caballero, Maria Meneghini, Irina B. Torres, Mariona Juvé, FMJ Hafkamp, Marta Vila, Alba G. Robles, Maria José Buzón, Nestor Toapanta, José Miguel Zúñiga, Víctor Monforte, Berta Saez-Giménez, Oscar Len, Ibai Los Arcos, Enric Miret, Gema Ariceta, Emma Pardo, Xavier Martínez, Francesc Moreso, Oriol Bestard
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionSolid organ transplant (SOT) recipients display weak seroconversion and neutralizing antibody (NAb) responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and remain at risk of severe coronavirus disease
Externí odkaz:
https://doaj.org/article/f97d7ea3e9b24df4960b49f99ad9f456
Autor:
Putita Chokmangmeepisarn, Saengchan Senapin, Suwimon Taengphu, Kim D. Thompson, Prapansak Srisapoome, Anurak Uchuwittayakul, Channarong Rodkhum
Publikováno v:
BMC Veterinary Research, Vol 20, Iss 1, Pp 1-20 (2024)
Abstract Background Scale drop disease virus (SDDV) threatens Asian seabass (Lates calcarifer) aquaculture production by causing scale drop disease (SDD) in Asian seabass. Research on the development of SDDV vaccines is missing an in-depth examinatio
Externí odkaz:
https://doaj.org/article/272c340b1b9747af92a24a5248e3a37a
Autor:
Cheryl Minn Jee Khoo, Eve Zhi Qing Dea, Li Yeow Law, Sharon Siew Tong Wong, Khuen Yen Ng, Athirah Bakhtiar
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Despite the high efficacy and safety demonstrated in clinical trials, COVID-19 booster vaccination rates in Malaysia remain below 50% among the general public. This study explores the factors influencing public acceptance of the COVID-19 boo
Externí odkaz:
https://doaj.org/article/f384758e4da64a3f809cf941d0f23e98